| abstract |
By using magnesium stearate in dry powder formulations for inhalation containing a non-pharmaceutically effective carrier in non-inhalable particle size and a finely divided pharmaceutical active ingredient in inhalable particle size, their moisture resistance can be improved and, accordingly, the storage stability increased and a high fine particle dose or fine particle fraction also be maintained under relatively extreme temperature and humidity conditions. |